Aug 19, 2021 / 11:30AM GMT
Operator
Hello, and welcome to the Sedana Medical Q2 Report 2021. (Operator Instructions)
Today, I'm pleased to present acting CEO, Jens Lindberg. Please begin your meeting.
Jens Lindberg - Sedana Medical AB(publ)-Acting CEO&VP of Commercial Operations
Thank you. And hi, and welcome, everyone. So for today's report, I will be joined by our CFO, Susanne Andersson; and our Chief Medical Officer, Peter Sackey.
So with that, let's get on with it, and we can move to the next slide, please, which is our disclaimer slide, which I guess we can move through relatively quickly. It's impossible to -- move the slides, please. There we go. And then the disclaimer slide, we can move to the next one as well, and I'll start with the quarterly highlights.
So this year, so if we look at Q2 and we look back, a couple of things. Clearly, first and foremost, quite happy about the approval of Sedaconda. We received the DCP approval in sort of July and then subsequently, the first national approval in France.
Q2 2021 Sedana Medical AB (publ) Earnings Call Transcript
Aug 19, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers